Loren Saulsberry

Assistant Professor
Research Summary
Loren Saulsberry is the Assistant Program Leader of the Cancer Prevention and Control Program within the UChicago Medicine Comprehensive Cancer Center and the Assistant Director of Diversity Studies in the UChicago Center for Personalized Therapeutics. As a health policy and health services researcher, Dr. Saulsberry investigates the experiences of vulnerable populations managing chronic conditions, especially those underrepresented and medically underserved. Her research interests include: (1) health policies and services that impact precision medicine delivered across the care continuum from prevention and early detection to cancer outcomes, (2) the relationships between politics and health communication, (3) the determinants contributing to health disparities affecting diverse populations, especially across race/ethnicity and socioeconomic status.
Keywords
Health Policy, Health Services Research, Cancer Prevention and Control, Precision Medicine, Pharmacogenomics, Health Disparities
Education
  • Harvard University , Boston, MA, Ph.D. Health Policy 05/2017
  • Wellesley College, Wellesley, MA, B.A. Neuroscience, English 05/2010
Biosciences Graduate Program Association
Awards & Honors
  • 2019 - North Coast Conference on Precision Medicine Travel Award Cleveland Institute for Computational Biology, Case Western Reserve University
  • 2020 - 2022 Human Genetics Scholar American Society of Human Genetics (ASHG)
  • 2022 - K Award Central Society for Clinical and Translational Research (CSCTR)
Publications
  1. "Everything in One Place": Stakeholder Perceptions of Integrated Medical and Social Care for Diabetes Patients in Western Maryland. J Gen Intern Med. 2023 03; 38(Suppl 1):25-32. View in: PubMed

  2. The social vulnerability metric (SVM) as a new tool for public health. Health Serv Res. 2022 Nov 19. View in: PubMed

  3. Quality of Care for US Adults With Medicaid Insurance and Type 2 Diabetes in Federally Qualified Health Centers Compared With Other Primary Care Settings. Med Care. 2022 11 01; 60(11):813-820. View in: PubMed

  4. Shifting the Paradigm: Reimagining Approaches to Diversifying the Leadership of the Nation's Cancer Centers. J Natl Cancer Inst. 2022 09 09; 114(9):1209-1211. View in: PubMed

  5. Effect Modification by Social Determinants of Pharmacogenetic Medication Interactions on 90-Day Hospital Readmissions within an Integrated U.S. Healthcare System. J Pers Med. 2022 Jul 15; 12(7). View in: PubMed

  6. Applicability of Pharmacogenomically Guided Medication Treatment during Hospitalization of At-Risk Minority Patients. J Pers Med. 2021 Dec 10; 11(12). View in: PubMed

  7. Underrepresented patient views and perceptions of personalized medication treatment through pharmacogenomics. NPJ Genom Med. 2021 Nov 01; 6(1):90. View in: PubMed

  8. Hypofractionated Radiation Therapy for Breast Cancer: Financial Risk and Expenditures in the United States, 2008 to 2017. Int J Radiat Oncol Biol Phys. 2022 03 01; 112(3):654-662. View in: PubMed

  9. Has Hypofractionated Whole-Breast Radiation Therapy Become the Standard of Care in the United States? An Updated Report from National Cancer Database. Clin Breast Cancer. 2022 01; 22(1):e8-e20. View in: PubMed

  10. Artificial Intelligence Can Cut Costs While Maintaining Accuracy in Colorectal Cancer Genotyping. Front Oncol. 2021; 11:630953. View in: PubMed

  11. Precision oncology: Directing genomics and pharmacogenomics toward reducing cancer inequities. Cancer Cell. 2021 06 14; 39(6):730-733. View in: PubMed

  12. Financing Diabetes Care in the U.S. Health System: Payment Innovations for Addressing the Medical and Social Determinants of Health. Curr Diab Rep. 2019 11 20; 19(11):136. View in: PubMed

  13. The Impact of Changes in Medicaid Provider Fees on Provider Participation and Enrollees' Care: a Systematic Literature Review. J Gen Intern Med. 2019 10; 34(10):2200-2209. View in: PubMed

  14. Perceptions of politicization and HPV vaccine policy support. Vaccine. 2019 08 14; 37(35):5121-5128. View in: PubMed

  15. The Impact of Breast Density Notification Laws on Supplemental Breast Imaging and Breast Biopsy. J Gen Intern Med. 2019 08; 34(8):1441-1451. View in: PubMed

  16. Challenges confronting African Americans and Hispanics living with chronic illness in their families. Chronic Illness. 2016; 4(12):281-291.::::

  17. Insurance coverage & Whither Thou Goest for health information in 2012. Medicare Medicaid Res Rev. 2014; 4(4):E1-E23.::::